330: Effects of the JAK3-Inhibitor R348 on Different Cell Types Involved in Obliterative Airway Disease

@article{Velotta2009330EO,
  title={330: Effects of the JAK3-Inhibitor R348 on Different Cell Types Involved in Obliterative Airway Disease},
  author={Jeffrey B. Velotta and Tobias Deuse and Christoph Peter and Esteban S. Masuda and Vanessa C. Taylor and Gary Park and David Carroll and Robert C. Robbins and Sonja Schrepfer},
  journal={Journal of Heart and Lung Transplantation},
  year={2009},
  volume={28}
}

Topics from this paper

The Potassium Channel KCa3.1 as New Therapeutic Target for the Prevention of Obliterative Airway Disease
TLDR
The findings suggest that KCa3.1 channels are involved in the pathogenesis of OAD and that the knockout or pharmacologic blockade holds promise to reduce OAD development.